Ribas-Mundo M - Search Results

1

Antiemetic efficacy of escalating doses of alizapride against chemotherapy-induced emesis.

Abad-Esteve A, Rosell R, Moreno I, Serichol M, Moya L, Ribas-Mundo M. Abad-Esteve A, et al. Oncology. 1989;46(4):235-7. doi: 10.1159/000226723. Oncology. 1989. PMID: 2740066

2

A randomized study comparing platinum, doxorubicin, and VP-16 with platinum, 4'-epidoxorubicin, and VP-16 in patients with non-small-cell lung cancer.

Rosell R, Abad-Esteve A, Morera J, Monras P, Moreno I, Ruiz J, Fernandez C, Ribas-Mundo M. Rosell R, et al. Am J Clin Oncol. 1987 Jun;10(3):245-8. doi: 10.1097/00000421-198706000-00017. Am J Clin Oncol. 1987. PMID: 3035913 Clinical Trial.

3

[Effectiveness of high-dose metoclopramide in the control of acute emesis induced by chemotherapy].

Rosell R, Abad-Esteve A, Ribas-Mundó M, Moreno I, Fernández-Marcial C. Rosell R, et al. Med Clin (Barc). 1987 Mar 14;88(10):434. Med Clin (Barc). 1987. PMID: 3573845 Spanish. No abstract available.

4

The role of combination cyclophosphamide, doxorubicin and cisplatin (CAP) chemotherapy in advanced non-small-cell lung cancer.

Rosell Costa R, Abad-Esteve A, Roig Cutilles J, Solorzano IM, Fernandez Marcial C, Ribas Mundo M. Rosell Costa R, et al. Tumori. 1987 Aug 31;73(4):345-9. doi: 10.1177/030089168707300405. Tumori. 1987. PMID: 3660472

5

[Evaluation of an antiemetic regimen with a high-dose metoclopramide, dexamethasone and diphenhydramine combination in chemotherapy regimens with cisplatin].

Abad-Esteve A, Rosell R, Moreno I, Monrás P, Fernández C, Serichol M, Clotet M, Ribas Mundó M. Abad-Esteve A, et al. Med Clin (Barc). 1986 Dec 6;87(19):796-8. Med Clin (Barc). 1986. PMID: 3821231 Spanish. No abstract available.

6

Evaluation of a combination antiemetic regimen including iv high-dose metoclopramide, dexamethasone, and diphenhydramine in cisplatin-based chemotherapy regimens.

Rosell R, Abad-Esteve A, Ribas-Mundo M, Moreno I. Rosell R, et al. Cancer Treat Rep. 1985 Jul-Aug;69(7-8):909-10. Cancer Treat Rep. 1985. PMID: 4040428 No abstract available.

7

[VP-16, vincristine, adriamycin and cyclophosphamide (EVAC) in patients with small-cell lung cancer].

Abad-Esteve A, Rosell R, Moreno I, Fernández-Marcial C, Roselló M, Ribas Mundó M. Abad-Esteve A, et al. Med Clin (Barc). 1988 Apr 9;90(14):569-72. Med Clin (Barc). 1988. PMID: 2840536 Spanish. No abstract available.

8

[Clinical use of hematopoietic growth factors (hematopoietins)].

Ribas-Mundó M, Ribas Bruguera A, Gale RP. Ribas-Mundó M, et al. Med Clin (Barc). 1993 May 8;100(18):707-11. Med Clin (Barc). 1993. PMID: 8492601 Review. Spanish. No abstract available.

9

The influence of nicardipine in patients with high risk of stroke.

Ribas Mundó M, Lozano R. Ribas Mundó M, et al. J Cardiovasc Pharmacol. 1990;16 Suppl 2:S16-9. J Cardiovasc Pharmacol. 1990. PMID: 1369703 Clinical Trial.

10

[Is the cure of acute myeloblastic leukemia in the adult possible?].

Ribas-Mundó M. Ribas-Mundó M. Med Clin (Barc). 1984 Dec 8;83(19):800-3. Med Clin (Barc). 1984. PMID: 6396459 Spanish. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

67 results

Search Page

Filters